Skip to main content
Top
Published in: World Journal of Surgery 7/2010

01-07-2010

Histone Deacetylase Inhibitors Attenuate Acute Lung Injury During Cecal Ligation and Puncture-Induced Polymicrobial Sepsis

Authors: Li Zhang, Shengwei Jin, Changdong Wang, Rong Jiang, Jingyuan Wan

Published in: World Journal of Surgery | Issue 7/2010

Login to get access

Abstract

Background

The histone deacetylase (HDAC) inhibitors have emerged as the useful reagents that epigenetically modulate the expression of various genes. In the present study, the effects of HDAC inhibitors on the expression of inflammation-related genes and lung injury during sepsis were investigated.

Methods

Mice were pretreated with two structurally unrelated HDAC inhibitors, Trichostatin A (TSA) and sodium butyrate (SB). Thirty minutes later, mice underwent cecal ligation and puncture (CLP)-induced sepsis. Lung injury and the expression of inflammation-related molecules were determined. In addition, survival was assessed post-CLP.

Results

Our results indicated that administration of TSA or SB alleviated sepsis-induced lung injury. This was accompanied by reduced neutrophil infiltration, decreased intercellular adhesion molecule-1 (ICAM-1) and E-selectin expression in lung tissue, and lower interleukin-6 (IL-6) level in plasma. In addition, treatment with HDAC inhibitors significantly prolonged the survival time of CLP mice.

Conclusions

These data indicated that the HDAC inhibitors, based on modulating the key enzymes linked to acetylation modification, effectively attenuate intrapulmonary inflammatory response, thus significantly alleviating lung injury during sepsis.
Literature
1.
2.
go back to reference Phua J, Badia JR, Adhikari NK et al (2009) Has mortality from acute respiratory distress syndrome decreased over time?: a systematic review. Am J Respir Crit Care Med 179:220–227CrossRefPubMed Phua J, Badia JR, Adhikari NK et al (2009) Has mortality from acute respiratory distress syndrome decreased over time?: a systematic review. Am J Respir Crit Care Med 179:220–227CrossRefPubMed
3.
go back to reference Balibrea JL, Arias-Díaz J (2003) Acute respiratory distress syndrome in the septic surgical patient. World J Surg 27:1275–1284CrossRefPubMed Balibrea JL, Arias-Díaz J (2003) Acute respiratory distress syndrome in the septic surgical patient. World J Surg 27:1275–1284CrossRefPubMed
4.
go back to reference Abraham E, Singer M (2007) Mechanisms of sepsis-induced organ dysfunction. Crit Care Med 35:2408–2416CrossRefPubMed Abraham E, Singer M (2007) Mechanisms of sepsis-induced organ dysfunction. Crit Care Med 35:2408–2416CrossRefPubMed
5.
go back to reference Kawai T, Akira S (2008) Toll-like receptor and RIG-I-like receptor signaling. Ann N Y Acad Sci 1143:1–20CrossRefPubMed Kawai T, Akira S (2008) Toll-like receptor and RIG-I-like receptor signaling. Ann N Y Acad Sci 1143:1–20CrossRefPubMed
6.
go back to reference Serhan CN, Chiang N, Van Dyke TE (2008) Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 8:349–361CrossRefPubMed Serhan CN, Chiang N, Van Dyke TE (2008) Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 8:349–361CrossRefPubMed
7.
go back to reference Berger SL (2007) The complex language of chromatin regulation during transcription. Nature 447:407–412CrossRefPubMed Berger SL (2007) The complex language of chromatin regulation during transcription. Nature 447:407–412CrossRefPubMed
9.
go back to reference Berger SL (2002) Histone modifications in transcriptional regulation. Curr Opin Genet Dev 12:142–148CrossRefPubMed Berger SL (2002) Histone modifications in transcriptional regulation. Curr Opin Genet Dev 12:142–148CrossRefPubMed
10.
go back to reference Yang XJ, Seto E (2007) HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention. Oncogene 26:5310–5318CrossRefPubMed Yang XJ, Seto E (2007) HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention. Oncogene 26:5310–5318CrossRefPubMed
11.
go back to reference Pan LN, Lu J, Huang B (2007) HDAC inhibitors: a potential new category of anti-tumor agents. Cell Mol Immunol 4:337–343PubMed Pan LN, Lu J, Huang B (2007) HDAC inhibitors: a potential new category of anti-tumor agents. Cell Mol Immunol 4:337–343PubMed
12.
go back to reference Mehnert JM, Kelly WK (2007) Histone deacetylase inhibitors: biology and mechanism of action. Cancer J 13:23–29CrossRefPubMed Mehnert JM, Kelly WK (2007) Histone deacetylase inhibitors: biology and mechanism of action. Cancer J 13:23–29CrossRefPubMed
13.
go back to reference Leoni F, Fossati G, Lewis EC et al (2005) The histone deacetylase inhibitor ITF2357 reduces production of pro-inflammatory cytokines in vitro and systemic inflammation in vivo. Mol Med 11:1–15CrossRefPubMed Leoni F, Fossati G, Lewis EC et al (2005) The histone deacetylase inhibitor ITF2357 reduces production of pro-inflammatory cytokines in vitro and systemic inflammation in vivo. Mol Med 11:1–15CrossRefPubMed
14.
go back to reference Choi JH, Oh SW, Kang MS et al (2005) Trichostatin A attenuates airway inflammation in mouse asthma model. Clin Exp Allergy 35:89–96CrossRefPubMed Choi JH, Oh SW, Kang MS et al (2005) Trichostatin A attenuates airway inflammation in mouse asthma model. Clin Exp Allergy 35:89–96CrossRefPubMed
15.
go back to reference Glauben R, Batra A, Fedke I et al (2006) Histone hyperacetylation is associated with amelioration of experimental colitis in mice. J Immunol 176:5015–5022PubMed Glauben R, Batra A, Fedke I et al (2006) Histone hyperacetylation is associated with amelioration of experimental colitis in mice. J Immunol 176:5015–5022PubMed
16.
go back to reference Lin HS, Hu CY, Chan HY et al (2007) Anti-rheumatic activities of histone deacetylase (HDAC) inhibitors in vivo in collagen-induced arthritis in rodents. Br J Pharmacol 150:862–872CrossRefPubMed Lin HS, Hu CY, Chan HY et al (2007) Anti-rheumatic activities of histone deacetylase (HDAC) inhibitors in vivo in collagen-induced arthritis in rodents. Br J Pharmacol 150:862–872CrossRefPubMed
17.
go back to reference Han SB, Lee JK (2009) Anti-inflammatory effect of Trichostatin-A on murine bone marrow-derived macrophages. Arch Pharm Res 32:613–624CrossRefPubMed Han SB, Lee JK (2009) Anti-inflammatory effect of Trichostatin-A on murine bone marrow-derived macrophages. Arch Pharm Res 32:613–624CrossRefPubMed
18.
go back to reference Iwata K, Tomita K, Sano H et al (2002) Trichostatin A, a histone deacetylase inhibitor, down-regulates interleukin-12 transcription in SV-40-transformed lung epithelial cells. Cell Immunol 218:26–33CrossRefPubMed Iwata K, Tomita K, Sano H et al (2002) Trichostatin A, a histone deacetylase inhibitor, down-regulates interleukin-12 transcription in SV-40-transformed lung epithelial cells. Cell Immunol 218:26–33CrossRefPubMed
19.
go back to reference Li Y, Liu B, Zhao H et al (2009) Protective effect of suberoylanilide hydroxamic acid against LPS-induced septic shock in rodents. Shock 32:517–523CrossRefPubMed Li Y, Liu B, Zhao H et al (2009) Protective effect of suberoylanilide hydroxamic acid against LPS-induced septic shock in rodents. Shock 32:517–523CrossRefPubMed
20.
go back to reference Sailhamer EA, Li Y, Smith EJ et al (2008) Acetylation: a novel method for modulation of the immune response following trauma/hemorrhage and inflammatory second hit in animals and humans. Surgery 144:204–216CrossRefPubMed Sailhamer EA, Li Y, Smith EJ et al (2008) Acetylation: a novel method for modulation of the immune response following trauma/hemorrhage and inflammatory second hit in animals and humans. Surgery 144:204–216CrossRefPubMed
21.
go back to reference Caldwell CC, Martignoni A, Leonis MA et al (2008) Ron receptor tyrosine kinase-dependent hepatic neutrophil recruitment and survival benefit in a murine model of bacterial peritonitis. Crit Care Med 36:1585–1593CrossRefPubMed Caldwell CC, Martignoni A, Leonis MA et al (2008) Ron receptor tyrosine kinase-dependent hepatic neutrophil recruitment and survival benefit in a murine model of bacterial peritonitis. Crit Care Med 36:1585–1593CrossRefPubMed
22.
go back to reference Rittirsch D, Huber-Lang MS, Flierl MA et al (2009) Immunodesign of experimental sepsis by cecal ligation and puncture. Nat Protoc 4:31–36CrossRefPubMed Rittirsch D, Huber-Lang MS, Flierl MA et al (2009) Immunodesign of experimental sepsis by cecal ligation and puncture. Nat Protoc 4:31–36CrossRefPubMed
23.
go back to reference van Griensven M, Probst C, Müller K et al (2006) Leukocyte-endothelial interactions via ICAM-1 are detrimental in polymicrobial sepsis. Shock 25:254–259CrossRefPubMed van Griensven M, Probst C, Müller K et al (2006) Leukocyte-endothelial interactions via ICAM-1 are detrimental in polymicrobial sepsis. Shock 25:254–259CrossRefPubMed
24.
go back to reference Rossi B, Constantin G (2008) Anti-selectin therapy for the treatment of inflammatory diseases. Inflamm Allergy Drug Targets 7:85–93CrossRefPubMed Rossi B, Constantin G (2008) Anti-selectin therapy for the treatment of inflammatory diseases. Inflamm Allergy Drug Targets 7:85–93CrossRefPubMed
25.
go back to reference Yang XJ, Seto E (2008) Lysine acetylation: codified crosstalk with other posttranslational modifications. Mol Cell 31:449–461CrossRefPubMed Yang XJ, Seto E (2008) Lysine acetylation: codified crosstalk with other posttranslational modifications. Mol Cell 31:449–461CrossRefPubMed
26.
go back to reference Halili MA, Andrews MR, Sweet MJ et al (2009) Histone deacetylase inhibitors in inflammatory disease. Curr Top Med Chem 9:309–319CrossRefPubMed Halili MA, Andrews MR, Sweet MJ et al (2009) Histone deacetylase inhibitors in inflammatory disease. Curr Top Med Chem 9:309–319CrossRefPubMed
27.
go back to reference Blanchard F, Chipoy C (2005) Histone deacetylase inhibitors: new drugs for the treatment of inflammatory diseases? Drug Discov Today 10:197–204CrossRefPubMed Blanchard F, Chipoy C (2005) Histone deacetylase inhibitors: new drugs for the treatment of inflammatory diseases? Drug Discov Today 10:197–204CrossRefPubMed
28.
go back to reference Wagner JG, Roth RA (2000) Neutrophil migration mechanisms, with an emphasis on the pulmonary vasculature. Pharmacol Rev 52:349–374PubMed Wagner JG, Roth RA (2000) Neutrophil migration mechanisms, with an emphasis on the pulmonary vasculature. Pharmacol Rev 52:349–374PubMed
29.
go back to reference Zemans RL, Colgan SP, Downey GP (2009) Transepithelial migration of neutrophils: mechanisms and implications for acute lung injury. Am J Respir Cell Mol Biol 40:519–535CrossRefPubMed Zemans RL, Colgan SP, Downey GP (2009) Transepithelial migration of neutrophils: mechanisms and implications for acute lung injury. Am J Respir Cell Mol Biol 40:519–535CrossRefPubMed
30.
go back to reference Reutershan J, Ley K (2004) Bench-to-bedside review: acute respiratory distress syndrome—how neutrophils migrate into the lung. Crit Care 8:453–461CrossRefPubMed Reutershan J, Ley K (2004) Bench-to-bedside review: acute respiratory distress syndrome—how neutrophils migrate into the lung. Crit Care 8:453–461CrossRefPubMed
31.
go back to reference Calandra T, Gerain J, Heumann D et al (1991) High circulating levels of interleukin-6 in patients with septic shock: evolution during sepsis, prognostic value, and interplay with other cytokines. Am J Med 91:23–29CrossRefPubMed Calandra T, Gerain J, Heumann D et al (1991) High circulating levels of interleukin-6 in patients with septic shock: evolution during sepsis, prognostic value, and interplay with other cytokines. Am J Med 91:23–29CrossRefPubMed
32.
go back to reference Gårdlund B, Sjölin J, Nilsson A et al (1995) Plasma levels of cytokines in primary septic shock in humans: correlation with disease severity. J Infect Dis 172:296–301PubMed Gårdlund B, Sjölin J, Nilsson A et al (1995) Plasma levels of cytokines in primary septic shock in humans: correlation with disease severity. J Infect Dis 172:296–301PubMed
33.
go back to reference Damas P, Ledoux D, Nys M et al (1992) Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann Surg 215:356–362CrossRefPubMed Damas P, Ledoux D, Nys M et al (1992) Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann Surg 215:356–362CrossRefPubMed
34.
go back to reference Cao W, Bao C, Padalko E et al (2008) Acetylation of mitogen-activated protein kinase phosphatase-1 inhibits Toll-like receptor signaling. J Exp Med 205:1491–1503CrossRefPubMed Cao W, Bao C, Padalko E et al (2008) Acetylation of mitogen-activated protein kinase phosphatase-1 inhibits Toll-like receptor signaling. J Exp Med 205:1491–1503CrossRefPubMed
35.
go back to reference Chen Lf, Fischle W, Verdin E et al (2001) Duration of nuclear NF-kappaB action regulated by reversible acetylation. Science 293:1653–1657CrossRef Chen Lf, Fischle W, Verdin E et al (2001) Duration of nuclear NF-kappaB action regulated by reversible acetylation. Science 293:1653–1657CrossRef
36.
go back to reference Chen LF, Greene WC (2003) Regulation of distinct biological activities of the NF-kappaB transcription factor complex by acetylation. J Mol Med 81:549–557CrossRefPubMed Chen LF, Greene WC (2003) Regulation of distinct biological activities of the NF-kappaB transcription factor complex by acetylation. J Mol Med 81:549–557CrossRefPubMed
37.
go back to reference Batta K, Das C, Gadad S et al (2007) Reversible acetylation of nonhistone proteins: role in cellular function and disease. Subcell Biochem 41:193–212CrossRefPubMed Batta K, Das C, Gadad S et al (2007) Reversible acetylation of nonhistone proteins: role in cellular function and disease. Subcell Biochem 41:193–212CrossRefPubMed
38.
go back to reference Das C, Kundu TK (2005) Transcriptional regulation by the acetylation of nonhistone proteins in humans—a new target for therapeutics. IUBMB Life 57:137–149CrossRefPubMed Das C, Kundu TK (2005) Transcriptional regulation by the acetylation of nonhistone proteins in humans—a new target for therapeutics. IUBMB Life 57:137–149CrossRefPubMed
39.
go back to reference Esmon CT (2004) Why do animal models (sometimes) fail to mimic human sepsis? Crit Care Med 32:S219–S222CrossRefPubMed Esmon CT (2004) Why do animal models (sometimes) fail to mimic human sepsis? Crit Care Med 32:S219–S222CrossRefPubMed
Metadata
Title
Histone Deacetylase Inhibitors Attenuate Acute Lung Injury During Cecal Ligation and Puncture-Induced Polymicrobial Sepsis
Authors
Li Zhang
Shengwei Jin
Changdong Wang
Rong Jiang
Jingyuan Wan
Publication date
01-07-2010
Publisher
Springer-Verlag
Published in
World Journal of Surgery / Issue 7/2010
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-010-0493-5

Other articles of this Issue 7/2010

World Journal of Surgery 7/2010 Go to the issue